BioAtla, Inc.
Public company- Headquarters
- SAN DIEGO, California
- Industry
- Biotechnology
- Ticker
- BCAB
- CIK
- 0001826892
WARN notices since 2024
0
None on record
Workers affected since 2024
0
Across 0 notices
Executive changes, last 12 months
1
0 appointments, 1 departure
Last event
Sep 29, 2026
Executive departureCMO departs: Eric Sievers
Workers affected over time
Cumulative workers in WARN notices since 2024
Not enough notices to chart yet.
Leadership
| Role and person | Since | Change |
|---|---|---|
| CMOEric Sievers | Sep 29, 2026 | Departed |
Related companies
Same industry and state, with recent events.
- Vir Biotechnology, Inc.
Class III director appointed: Suzanne Topalian, M.D.
- AMGEN INC
director appointed: David W. Gibbs
- Cardiff Oncology, Inc.
CMO appointed: Leila Alland
- Vaxart, Inc.
member of the Board appointed: Raquel C. Bono, M.D., M.B.A., FACS
- Executive departure
CMO departs: Eric Sievers
Eric Sievers, Chief Medical Officer of BioAtla, Inc., resigns the role, effective September 25, 2026. The company reported the change in an 8-K that cites Item 5.02.
Source: SEC 8-K, filed Sep 29, 2026Role: Chief Medical Officer
Only one public record so far. We add events as soon as a new filing lands; watch BioAtla, Inc. to get them in your digest.
Last verified Nov 8, 2026